Table 1 Baseline characteristics.
From: Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement
Baseline Characteristics | Co-trimoxazole Group (n = 16) | Placebo Group (n = 15) |
|---|---|---|
Median age (yr) | 46.1 (21.1-56.5) | 51.4 (28.4-76.0) |
Sex (M/F) | 8/8 | 7/8 |
Disease duration (mo) | 67 (8-86) | 66 (7-71) |
BVAS-WG | 8 (2-11) | 11 (12-14) |
DEI | 4 (3-8) | 5 (3-7) |
GFR (ml/min) | 81 (74-110) | 71 (486-88) |
Length of remission (mo) | 15 | 16 |
Positive serum test for PR3 at the start of treatment | 7 | 9 |